Abstract:Abstract A 39-year-old man with intermediate junctional epidermolysis bullosa (EB) was admitted with a 2-week history of nausea, vomiting, diarrhoea, weakness, loss of appetite and abdominal pain. He described worsening pain within his chronic wounds, which were widespread, crusted and producing extensive green exudate. On admission, he was hypotensive, tachycardic and pyrexial. Investigations showed anaemia (haemoglobin 86 g L−1), hyponatraemia (132 mmol L−1), hypokalaemia (3.3 mmol L−1), raised lactate (3.29 mmol L−1), raised C-reactive protein (263 mg L−1), and leucocytosis (white cell count 22.2 × 109 L−1, neutrophils 10.5 × 109 L−1, and eosinophils 1.88 × 109 L−1). Despite treatment for sepsis secondary to cutaneous infection, inflammatory markers remained high, and the wounds deteriorated, with continuous production of yellow exudate, increasing pain and new blistering. Additionally, medical interventions failed to resolve persistent abdominal symptoms, haemodynamic compromise and pyrexia. On further review, the dermatology team noted that, unbeknownst to them, the patient had been prescribed 100 g of clobetasol propionate monthly by his general practitioner for at least the last year. Adrenal insufficiency was suspected and subsequently confirmed by a 09.00 h cortisol test (79 nmol L−1). The dermatology team initiated a 100-mg intravenous hydrocortisone bolus, followed by a 6-hourly 50-mg regimen, with consequent resolution of hypotension, tachycardia, pyrexia, hyponatraemia and eosinophilia. Targeted antibiotic therapy (tazobactam and vancomycin), 50 : 50 ointment and wound management improved inflammatory signs. The endocrinology team confirmed secondary adrenal insufficiency and provided a steroid emergency kit and advice on sick day rules at point of discharge. Adrenal crisis in secondary adrenal insufficiency is a life-threatening medical emergency requiring immediate intervention. In this case, adrenal insufficiency was caused by repeated exposure to excessive exogenous topical corticosteroids, and acute wound infection precipitated adrenal crisis. Given the nonspecific presentation, adrenal crisis is frequently overlooked in favour of other more common differential diagnoses. However, eosinophilia, hypotension, unresolving pyrexia and ongoing acute systemic inflammatory response symptoms aid accurate diagnosis. This patient’s hypokalaemia was likely secondary to vomiting, highlighting the importance of clinical context, as hyperkalaemia is more commonly noted during adrenal crisis. Most importantly, this case highlights the importance of clinician-led corticosteroid stewardship and the need for a higher index of suspicion for adrenal insufficiency in patients with a history of significant topical corticosteroid use.

Symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature

The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids

Cephalosporin-Induced Atypical DRESS Syndrome; a Tale of Two Cases

High-risk drug rashes

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic

Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence

Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review

Demystifying drug reaction with eosinophilia and systemic symptoms (DRESS): a review of the literature and guidelines for management

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature

An Unusual Case Report and Review of the Literature

Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug

Effectiveness and Safety of Early Short-Course, Moderate- to High-Dose Glucocorticoids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Retrospective Study

Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text]

SG15 A topical matter: iatrogenic adrenal crisis following excessive prescription corticosteroid use

Medication Associations with Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System

Updates and Insights in the Diagnosis and Management of DRESS Syndrome

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

[What's new in clinical dermatology?]

Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances